Prediction of Specific Antibody- and Cell-Mediated Responses Using Baseline Immune Status Parameters of Individuals Received Measles-Mumps-Rubella Vaccine. [PDF]
Toptygina A, Grebennikov D, Bocharov G.
europepmc +1 more source
Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases. [PDF]
Al-Qassabi AM, Al Kindi A.
europepmc +1 more source
The Influence of Sex, Body Mass Index, and Age on Cellular and Humoral Immune Responses Against Measles After a Third Dose of Measles-Mumps-Rubella Vaccine. [PDF]
Quach HQ +9 more
europepmc +1 more source
Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults. [PDF]
Kaaijk P +7 more
europepmc +1 more source
Measles Virus Neutralizing Antibody Response and Durability Two Years after One or Two Doses of Measles-Mumps-Rubella Vaccine among Young Seronegative Healthcare Workers. [PDF]
Jang B +5 more
europepmc +1 more source
Number of doses of Measles-Mumps-Rubella vaccine applied in Brazil before and during the COVID-19 pandemic. [PDF]
da Silva TMR +5 more
europepmc +1 more source
Influence of measles-mumps-rubella vaccine series initiation and completion on influenza vaccination among adolescents. [PDF]
Beeninga FT +4 more
europepmc +1 more source
Reply to Özdemir, "Measles-Mumps-Rubella Vaccine and COVID-19 Relationship". [PDF]
Fidel PL, Noverr MC.
europepmc +1 more source

